metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Compromiso ocular en el sarcoma de Kaposi asociado con el sida
Journal Information
Vol. 19. Issue 1.
Pages 3-6 (January 2001)
Share
Share
Download PDF
More article options
Vol. 19. Issue 1.
Pages 3-6 (January 2001)
Full text access
Compromiso ocular en el sarcoma de Kaposi asociado con el sida
Ocular manifestations of Kaposi’s sarcoma associated with the acquired immune deficiency syndrome
Visits
12567
Marcelo Corti1
Corresponding author
marcelocorti@ciudad.com.ar

Correspondencia: Dr. M. Corti. Rivadavia 8326 4to ‘A’ (1407). Buenos Aires (Capital). Argentina.
, Rubén Solari, Luis de Carolis, Rosa Corraro
Unidades 10 -11 y Servicio de Oftalmología. Hospital de Infecciosas. F. J. Muñiz Buenos Aires. Argentina
This item has received
Article information
Fundamento

Evaluar la incidencia del compromiso ocular en el sarcoma de Kaposi asociado con el sida.

M étodos

Se revisaron las consultas efectuadas en el servicio de Oftalmología entre enero de 1994 y diciembre de 1998 por personas infectadas por el virus de la inmunodeficiencia humana (VIH). Todos ellos fueron sometidos a examen oftalmológico directo, fondo de ojo, biomicroscopia y examen con lámpara de hendidura.

Resultados

En 6.552 consultas, se diagnosticó compromiso ocular por el sarcoma de Kaposi en 17 pacientes, lo que significa una incidencia del 0,25%. La media del recuento de linfocitos T CD4 fue de 172 células /mm3. Las lesiones predominaron en el sexo masculino (88,23%). La estructura ocular afectada con mayor frecuencia fueron los párpados, siendo el inferior el más comprometido. En una de las mujeres afectadas, la localización ocular constituyó la primera y única manifestación de la neoplasia.

Conclusión

El compromiso ocular en el sarcoma de Kaposi es una alternativa que debe considerarse en sujetos con infección por VIH, con compromiso previo de piel y otras mucosas. Dada la escasa repercusión clínica de las lesiones, recomendamos efectuar un minucioso examen ocular en estos pacientes.

Palabras clave:
sarcoma de Kaposi
sida
ojos
Background

The study evaluates the incidence of ocular compromise in the Kaposi’s sarcoma associated with AIDS.

Methods

We revised the clinical histories of HIV seropositives patients seen in the ophtalmologie departament from January, (1994) to December, (1998). All patients were examined by direct visually and dilated fundus examination with the use of either a direct or an indirect ophtalmoscope.

Results

In 6,552 patients, ocular Kaposi’s sarcoma was diagnosed in 17 (0.25%), predominantly in male sex (88.23%). The lesions predominated in eyelids, and the inferior been the most affected. In only one female, the ocular compromise was the first neoplasic manifestation.

Conclusions

The ocular compromise in the Kaposi’s sarcoma is an alternative to be considered in AIDS patients with previous or simultaneous cutaneous or visceral involvement. Due to the few clinical signs of these lesions, a thorough ocular study is recommended in these patients.

Keywords:
Kaposi’s sarcoma
AIDS
eyes
Full text is only aviable in PDF
Bibliografía
[1.]
J.P. Dunn, G.N. Holland.
AIDS and eye: concepts and emerging problems.
Current practice in ophtalmolgy, pp. 1-31
[2.]
C.J. Cockerell.
Neoplastic disorders.
J Intern Assoc Physic AIDS Care, (1995), pp. 23-28
[3.]
M. Kalinske, C.Jr. Leone.
Kaposi’s sarcoma involving eyelid and conjunctiva.
Ann Ophthalmol, 14 (1982), pp. 497
[4.]
J.B. Shuler, G.N. Holland, S.A. Miles, B.J. Miller, I. Grossman.
Kaposi’s sarcoma of the conjunctiva and eyelids associated with the acquired immunodeficiency syndrome.
Arch Ophthalmol, 107 (1989), pp. 858-862
[5.]
W.R. Freeman, J.G. Gross.
Management of ocular disease in AIDS patients.
Ophthalmol Clin North Amer, 1 (1988), pp. 91-100
[6.]
G.N. Holland, J.S. Pepose, T.H. Pettit, M.S. Gottlieb, R.D. Yee, R.Y. Foos.
Acquired immunodeficiency syndrome. Ocular manifestations.
Ophthalmology, 90 (1983), pp. 859
[7.]
A. Macher, A. Palestine, H. Masur, G. Bryant, C.H. Chan, R.B. Nussenblatt, et al.
Multicentric Kaposi’s of the conjunctiva in a homosexual male with the acquired immunodeficiency syndrome.
Ophthalmology, 90 (1983), pp. 879
[8.]
U.R. Kurumety, J.M. Lustbader.
Kaposi’s sarcoma of the bulbar conjunctiva as an initial clinical manifestation of acquired immunodeficiency syndrome.
Arch Ophthalmol, 113 (1995), pp. 978
[9.]
N. Murray, P. Mc Cluskey, D. Wakefield, P. Beaumont.
Isolated bulbar conjunctival Kaposi’s sarcoma.
Aust NZ J Ophthalmol, 22 (1994), pp. 81
[10.]
S.C. Brun, F.A. Jakobiec.
Kaposi’s sarcoma of the ocular adnexa.
Int Ophthalmol Clin, 37 (1997), pp. 25-38
[11.]
F. Samaniego, P.D. Markham, R.C. Gallo, B. Ensoli.
Inflammatory cytokines induce AIDS-Kaposi’s sarcoma derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s sarcoma-like lesion formation in nude mice.
J Immunol, 154 (1995), pp. 3.582-3.592
[12.]
L. Jaimovich, I. Calb, A. Kaminnsky.
Kaposi’s sarcoma of the conjuntiva.
J Am Acad Dermatol, 14 (1986), pp. 589-592
[13.]
G.N. Holland, M.S. Gottlieb, R.D. Yee, H.M. Schanker, T.H. Pettit.
Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome.
Am J Ophthalmol, 93 (1982), pp. 393-402
[14.]
Safai B. Kaposi’s sarcoma (idiopatic multiple pigmented sarcoma). En: Fraunfelder FT, Roy FM, eds. Current ocular therapy (5 th. ed). Philadelphia: W.B. Saunders, in press.
[15.]
G.N. Holland.
Ocular sequelae.
Textbook of AIDS Medicine, pp. 473-487
[16.]
P.U. Dugel, P.S. Gill, G.T. Frangieh, N.A. Rao.
Ocular adnexal Kaposi’s sarcoma in acquired immuinodeficiency syndrome.
Am J Ophthalmol, 110 (1990), pp. 500-503
[17.]
Andreu D, Gómez M, Cano J, Díaz M, Adán A, Jou A. Ophtalmologic manifestations of AIDS in Spain: national multicentric study of 758 patients. Multicentric Study Group of Uveítis. 9th World AIDS Conference, Berlín 1993; (abstract N° PO-B16-1711).
[18.]
J. Bañuelos, M.A. González Ortiz, O. Sayagues Gómez, C. Barros Aguado.
Afección ocular en los pacientes con SIDA.
Rev Clin Esp, 193 (1993), pp. 393-400
[19.]
Nouts C, Morlat Ph, Dequae L, Pellegrin JL. Extra-cutaneous manifestations of AIDS-related Kaposi’s sarcoma: a retrospective study of 80 cases. 11th World AIDS Conference, Vancouver 1996, (abastract N° Mo.B. 1250).
[20.]
P. Le Hoang, B. Girard, F. Rouselie.
Oeil et SIDA.
Ophtalmologie, 3 (1989), pp. 60-62
[21.]
R. Ghabrial, J.M. Quivey, J.P. Dunn, D.H. Char.
Radiation therapy of acquired immunodeficiency syndrome-related Kaposi’s sarcoma of the eyelids and conjunctiva.
Arch Ophthalmol, 110 (1992), pp. 1.423-1.426
[22.]
P.U. Dugel, P.S. Gill, G.T. Frangieh, N.A. Rao.
Treatment of ocular adnexal Kaposi’a sarcoma in acquired immunodeficiency syndrome.
Ophthalmology, 99 (1992), pp. 1.1127-1.1132
[23.]
J.S. Cooper, P.R. Fried.
Treatment of agresive epidemic Kaposi’s sarcoma of the conjunctiva by radiotherapy.
Arch Ophthalmol, 106 (1988), pp. 20-21
[24.]
O.H. Visser, P.J. Bos.
Kaposi’s sarcoma of the conjunctiva and CMV-retinitis in AIDS.
Doc Ophthalmol, 64 (1986), pp. 77-85
[25.]
D.B. Soll, E.G. Redovan.
Kaposi’s sarcoma of the eyelid as the initial manifestation of AIDS.
Ophthal Plast Reconstr Surg, 5 (1989), pp. 49-51
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos